Financhill
Back

Hikma Pharmaceuticals Plc 10K Form

Sell
30

HKMPF
Hikma Pharmaceuticals Plc

Last Price:
$19.98
Seasonality Move:
-2.83%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HKMPF News And Ratings

See the #1 stock for the next 7 days that we like better than HKMPF

HKMPF Financial Statistics

Sales & Book Value

Annual Sales: $3.1B
Cash Flow: $0
Price / Cash Flow: 29.28
Annual Sales: $11.46
Price / Book: 2.09

Profitability

EPS (TTM): 1.68000
Net Income (TTM): $373M
Gross Margin: $1.3B
Return on Equity: 15.52%
Return on Assets: 7.17%

Hikma Pharmaceuticals Plc Earnings Forecast

Key Hikma Pharmaceuticals Plc Financial Ratios

  • The Gross Profit Margin over the past 23 years for HKMPF is 42.44%.
  • The Selling, General & Administrative Expenses for HKMPF have been equal to 21.46% of Gross Profit Margin.
  • The Research & Development expenses have been 4.51% of Revenue.
  • The Interest Expense is 24.31% of Operating Income.
  • The Net Earning history of HKMPF is 11.58% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 14 years.

Hikma Pharmaceuticals Plc Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: HKMPF
Website: hikma.com

Debt

Debt-to-Equity Ratio: 0.59
Current Ratio: 1.24
Quick Ratio: 0.65

Price-to-Earnings

Trailing P/E Ratio: 12.44
Forward P/E Ratio: 0

HKMPF Technical Analysis vs Fundamental Analysis

Sell
30
Hikma Pharmaceuticals Plc (HKMPF) is a Sell

Is Hikma Pharmaceuticals Plc a Buy or a Sell?